Uncategorized

Baird’s Top Tech Stocks to Consider on Market Sell-Off: Alibaba (BABA), Apple (AAPL), Intel (INTC)

Given the recent firestorm of selling in tech, Baird’s Technology Research team is highlighting underperforming stocks that they believe are positioned for stronger …

Apple (AAPL) Stock: Next Stop, $275?

Tech giant Apple (NASDAQ:AAPL) reported fiscal third-quarter results with revenue and EPS ahead of Street estimates due to strong iPhone ASPs and record Services revenue …

DPW Holdings’ (DPW) Enertec Systems Wins $4.3 Million Contract Award; Shares Climb

DPW Holdings Inc (NYSE:DPW) announced this morning that Enertec Corporation, the Israel-based defense solutions group of DPW subsidiary Coolisys Technologies, was awarded a $4.3 …

SenesTech (SNES) Shares Storm Higher on Distribution Agreement News

SenesTech (NASDAQ:SNES) shares are shooting up 18% faster than Jack’s magic bean sparking right into a giant beanstalk. The reason?

Cara Therapeutics (CARA) Gains as VF Comes to Rescue

Cara Therapeutics’ (NASDAQ:CARA) long-suffering bulls finally have reason to celebrate: The biotech firm announced this morning a license and co-promotion agreement with Vifor Fresenius …

General Electric (GE): Newest 50 MW Wind Farm Targets More Renewable Energy Growth in Pakistan

General Electric (NYSE:GE) Renewable Energy joins Hawa Energy on the Hawa Power Project, the fourth 50 MW project in Pakistan to boast the …

SELLAS Life Sciences Group’s (SLS) NeuVax Gets a Solid Boost; H.C. Wainwright Cheers

SELLAS Life Sciences Group (NASDAQ:SLS) shares are up sharply on the announcement of positive interim data in breast cancer for NeuVax + Herceptin, including …

BlueLinx Holdings Inc. (BXC) Enhances Its Product Portfolio With Cedar Creek Acquisition

BlueLinx Holdings Inc. (NYSE:BXC) shares are shooting up 77% faster than Jack’s magic bean sparking right into a giant beanstalk.

Sorrento Therapeutics Inc (SRNE): This Analyst Thinks the Stock Can Go To $38

A number of biotech companies, including Sorrento Therapeutics Inc (NASDAQ:SRNE), have staked a lot on CAR-T therapies for cancer patients. Yesterday, Sorrento reported initial results …